Where Does Aeglea Bio Therapeutics Inc (AGLE) Stock Fall in the Biotechnology Field After It Has Fallen -12.97% This Week?

Wednesday, October 04, 2023 01:52 PM | InvestorsObserver Analysts

Mentioned in this article

Where Does Aeglea Bio Therapeutics Inc (AGLE) Stock Fall in the Biotechnology Field After It Has Fallen -12.97% This Week?

A rating of 76 puts Aeglea Bio Therapeutics Inc (AGLE) near the top of the Biotechnology industry according to InvestorsObserver. Aeglea Bio Therapeutics Inc's score of 76 means it scores higher than 76% of stocks in the industry. Aeglea Bio Therapeutics Inc also received an overall rating of 56, putting it above 56% of all stocks. Biotechnology is ranked 73 out of the 148 industries.

AGLE has an Overall Score of 56. Find out what this means to you and get the rest of the rankings on AGLE!

See Full AGLE Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Aeglea Bio Therapeutics Inc Stock Today?

Aeglea Bio Therapeutics Inc (AGLE) stock is lower by -11.5% while the S&P 500 has gained 0.3% as of 1:49 PM on Wednesday, Oct 4. AGLE is down -$1.30 from the previous closing price of $11.30 on volume of 32,588 shares. Over the past year the S&P 500 has gained 11.90% while AGLE is down -24.24%. AGLE lost -$71.45 per share the over the last 12 months. Click Here to get the full Stock Report for Aeglea Bio Therapeutics Inc stock.